P Armand - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P Armand

Showing results (161-170 of 240) with videos related to

Pageof 24

Sort By:

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patientsM de Forni, G G Chabot, J P Armand, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993

Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive casesE Cvitkovic, M Bachouchi, H Boussen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000

Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancerV Boige, E Raymond, S Faivre, et al.

Oncogene|March 16, 1995

High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesionsJ C Ahomadegbe, M Barrois, S Fogel, et al.

Acta Clinica Belgica. Supplementum|January 1, 1986

[Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day]J Bonneterre, H Coppens, L Mauriac, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Phase II trial of pirarubicin in epidermoid carcinoma of the head and neckP Cappelaere, N Guiochet, J Chauvergne, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999

Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancerM Ducreux, M Ychou, J F Seitz, et al.

International Journal of Radiation Oncology, Biology, Physics|June 15, 1995

Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomasJ Bourhis, A Fortin, O Dupuis, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal typeN Azli, J P Armand, M Rahal, et al.

Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1994

[Re-irradiation and concomitant chemotherapy in unresectable locoregional recurrence of cancers of the upper respiratory-digestive tract]J Bourhis, C Domenge, A Fortin, et al.

Pageof 24

Search research articles

Showing results (161-170 of 240) with videos related to

Sort By:

Pageof 24

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patientsM de Forni, G G Chabot, J P Armand, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000

Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancerV Boige, E Raymond, S Faivre, et al.

Oncogene|March 16, 1995

Acta Clinica Belgica. Supplementum|January 1, 1986

[Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day]J Bonneterre, H Coppens, L Mauriac, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Phase II trial of pirarubicin in epidermoid carcinoma of the head and neckP Cappelaere, N Guiochet, J Chauvergne, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999

International Journal of Radiation Oncology, Biology, Physics|June 15, 1995

Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomasJ Bourhis, A Fortin, O Dupuis, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1994

[Re-irradiation and concomitant chemotherapy in unresectable locoregional recurrence of cancers of the upper respiratory-digestive tract]J Bourhis, C Domenge, A Fortin, et al.

Pageof 24